Please try another search
For the fiscal year ended 31 December 2021, Bioelectronics Corp revenues increased 94% to $1.6M. Net loss decreased 75% to $290K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other General and Administrative Expense decrease of 44% to $327K (expense), Research and Development decrease of 32% to $328K (expense).
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Revenue | 0.18 | 0.41 | 0.41 | 0.6 |
Gross Profit | 0.03 | 0.28 | 0.21 | 0.27 |
Operating Income | -0.04 | -0.01 | -0.03 | -0.07 |
Net Income | -0.13 | 0.02 | -0.05 | -0.14 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Assets | 0.08 | 0.42 | 0.61 | 0.32 |
Total Liabilities | 15.2 | 15.7 | 15.91 | 15.57 |
Total Equity | -15.12 | -15.28 | -15.3 | -15.25 |
Period Ending: | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Period Length: | 12 Months | 9 Months | 6 Months | 3 Months |
Cash From Operating Activities | -0.32 | -0.38 | -0.25 | -0.24 |
Cash From Investing Activities | 0 | 0 | ||
Cash From Financing Activities | 0.21 | 0.34 | 0.22 | 0.15 |
Net Change in Cash | -0.11 | -0.05 | -0.02 | -0.09 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review